Jefferies Group’s Medicines Co MDCO Stock Holding History

Jefferies Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-45,000	Closed	-$3.82M	–	2950
2019 Q4	$3.82M	Sell	45,000 -13,000	-22%	-$867K	0.03%	655
2019 Q3	$2.9M	Buy	58,000 +28,000	+93%	+$1.12M	0.02%	829
2019 Q2	$1.09M	Hold	30,000	–	–	0.01%	1240
2019 Q1	$839K	Buy	30,000 +20,000	+200%	+$471K	0.01%	1356
2018 Q4	$191K	Buy	+10,000	New	+$233K	﹤0.01%	1844
2016 Q1	–	Sell	-39,300	Closed	-$1.47M	–	2717
2015 Q4	$1.47M	Buy	+39,300	New	+$1.49M	0.01%	1004

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Jefferies Group's MDCO Position: Q1 2020 in Review

Jefferies Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 158,197 shares — an estimated $13.4M sold.

Jefferies Group first reported a position in MDCO in Q4 2013 and held it in 14 quarters. The position peaked at $13.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Jefferies Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 158,197 Medicines Co shares in Q1 2020, an estimated $13.4M.
Jefferies Group first reported a position in Medicines Co in Q4 2013 and held it in 14 quarters.
Jefferies Group's Medicines Co position peaked at $13.4M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.